← Leaderboards
Kenneth Aldape
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Dna Methylation”
- Richard K. Wilson · Washington University$74,307,196
- Bing Ren · Ludwig Institute For Cancer Research$63,053,519
- Leonardo Trasande · New York University School Of Medicine$50,897,521
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$47,754,231
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$46,590,951
- Joseph R Ecker · University Of California, San Diego$45,558,745
Research focus
Dna MethylationTumorMethylationGenomicsMalignant NeoplasmsMolecularHeterogeneityExcisionNeoplastic CellDiagnosisRecurrenceSamplingTumor ProgressionBrain NeoplasmsBrainCellsAdjuvant RadiotherapyMutationMeningiomaCessation Of LifeIntracranial NeoplasmsGene ExpressionBehaviorAdjuvant
Grant awards (23)
Genomic Biomarkers of Cancer$608,246
ZIA · FY2025 · CA · contact PI
Development and validation of a predictor of meningioma recurrence$590,358
ZIA · FY2025 · CA · contact PI
Single-cell DNA methylation analysis of human cancer$590,358
ZIA · FY2025 · CA · contact PI
Genomic Biomarkers of Cancer$696,418
ZIA · FY2024 · CA · contact PI
Development and validation of a predictor of meningioma recurrence$675,934
ZIA · FY2024 · CA · contact PI
Single-cell DNA methylation analysis of human cancer$675,934
ZIA · FY2024 · CA · contact PI
Genomic Biomarkers of Cancer$695,923
ZIA · FY2023 · CA · contact PI
Single-cell DNA methylation analysis of human cancer$675,454
ZIA · FY2023 · CA · contact PI
Development and validation of a predictor of meningioma recurrence$675,454
ZIA · FY2023 · CA · contact PI
Genomic Biomarkers of Cancer$1,282,387
ZIA · FY2022 · CA · contact PI
Single-cell DNA methylation analysis of human cancer$1,244,669
ZIA · FY2022 · CA · contact PI
Development and validation of a predictor of meningioma recurrence$1,244,669
ZIA · FY2022 · CA · contact PI
Genomic Biomarkers of Cancer$819,724
ZIA · FY2021 · CA · contact PI
Development and validation of a predictor of meningioma recurrence$795,613
ZIA · FY2021 · CA · contact PI
Single-cell DNA methylation analysis of human cancer$795,613
ZIA · FY2021 · CA · contact PI
Genomic Biomarkers of Cancer$810,474
ZIA · FY2020 · CA · contact PI
Single-cell DNA methylation analysis of human cancer$786,638
ZIA · FY2020 · CA · contact PI
Development and validation of a predictor of meningioma recurrence$786,638
ZIA · FY2020 · CA · contact PI
Single-cell DNA methylation analysis of human cancer$3,296,269
ZIA · FY2019 · CA · contact PI
Development and validation of a predictor of meningioma recurrence$1,038,551
ZIA · FY2019 · CA · contact PI
Genomic Biomarkers of Cancer$180,617
ZIA · FY2019 · CA · contact PI
Single-cell DNA methylation analysis of human cancer$307,906
ZIA · FY2018 · CA · contact PI
Development and validation of a predictor of meningioma recurrence$102,635
ZIA · FY2018 · CA · contact PI